Go to navigation Go to content AstraZeneca Internationall AstraZeneca United Kingdom View AstraZeneca Global Website Careers Media Other websites Home AstraZeneca in the UK Our Research Medicines Supporting science Community support The true cost of cardiovascular disease in Europe Read story Latest research papers 28 August 2014 Estimating the cost burden of cardiovascular disease – now and in the future 29 August 2014 Secondary prevention of cardiovascular disease: new recommendations from the World Heart Federation Watch animation Latest from LabTalk Harriet Fear, CEO One Nucleus, discusses AstraZeneca and the Cambridge ecosystem Read Harriet's blog post Mark Wigglesworth, Director High Throughput Screening, talks about AZ’s plans for a world leading Lead Discovery centre in Cambridge, UK Read Mark's blog post AstraZeneca in the UK Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that. AstraZeneca is a major contributor to UK science and innovation investment, economic prosperity and to patient health. Read more about our UK presence About our use of cookies Privacy policy Legal notice © AstraZeneca 2014